Structural understanding of Mu transposition
Mu转置的结构理解
基本信息
- 批准号:8459942
- 负责人:
- 金额:$ 29.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibiotic ResistanceArchitectureBacteriophagesBindingBinding SitesBiochemicalBiological AssayBiotechnologyC-terminalCatalytic DomainChimera organismCollaborationsComplexCrystallizationCrystallographyDNADNA BindingDNA Binding DomainDNA StructureDNA TransposonsDNA-Protein InteractionData SetDissectionDropsElementsEngineeringEnhancersEnzymesEvolutionFamilyFamily memberFluorescence Resonance Energy TransferHIVIn VitroIntegraseInvestigationLeftMeasuresMobile Genetic ElementsModelingNaturePathway interactionsPeptide HydrolasesPhysiologicalPlayProtein EngineeringProteinsProtomerReactionRegulationResolutionRestRetroviridaeRoleSolutionsStagingStructureSystemTestingTranslatingTransposaseVDJ RecombinasesVariantWorkbasechemical reactioncomplex Rfluorophoreimprovedin vitro Assayinterestluminescence resonance energy transfermu transposasemutantpreventprotein protein interactionpublic health relevancerapid techniquerecombinasereconstructionresearch studyscreeningsingle moleculesingle-molecule FRETtooltransposon/insertion elementunfoldasevector
项目摘要
DESCRIPTION (provided by applicant): This work will combine crystallographic and biochemical studies to understand the organization and regulation of a classic DNA transposase that is now a biotech tool, that of bacteriophage Mu. This is the most thoroughly characterized of the large and highly diverse "DDE" family of transposases and retroviral integrases, and studies of Mu will continue to illuminate paradigms that translate to the rest of the family. Preliminary results include a recently-determined structure of an active Mu transposase - DNA complex, which contains 240 kDa of protein and 135bp of DNA. This is the largest and most complex structure of any transposase-DNA structure to date, and only the 2nd DDE recombinase to be crystallized with target DNA. This structure is serving as the springboard for further studies. AIM 1 is to complete the current structure and to obtain the highest resolution crystal form possible. The current structure guided the construction of an active but more compact chimeric transposase with a different DNA binding domain that may aid crystallization, will facilitate in vitro experiments in our lab and others', and may aid in engineering the system to be more useful as a biotech tool. AIM 2 is to understand the conformational changes that underlie increasing stability and ClpX recognition. Our structure suggests a model for how product binding energy is used by transposases to drive forward an otherwise isoenergetic chemical reaction, and how the extremely stable final complex can be preferentially recognized by the ATP-dependent unfoldase ClpX. This aim uses bulk and single-molecule FRET and LRET, as well as some crystallography and solution assays. AIM 3 is to understand the structural basis for assembly of with full left and right phage ends. Although an active complex requires only 4 copies of the transposase (which is what we have crystallized), the right and left ends of the phage contain different arrays of 3 transposase binding sites each. Our structure provides a basis for testable hypotheses regarding why the left end differs from the right and how it is incorporated into the final complex. This work will involve complex formation and activity assays with carefully chosen mutants specifically targeted to different binding sites. A detailed understanding of this system will provide an informative example for understanding why many other mobile DNA elements have different left and right ends, with seemingly-extra recombinase binding sites.
描述(由申请人提供):这项工作将结合晶体学和生化研究,以了解经典DNA转座酶的组织和调节,该酶现在是一种生物技术工具,即噬菌体MU。这是最彻底的,高度多样化的转座酶和逆转录病毒整合酶家族的特征,对MU的研究将继续照亮转化为家族其他成员的范式。初步结果包括活性MU转座酶-DNA复合物的最近确定的结构,该结构含有240 kDa的蛋白质和135bp的DNA。这是迄今为止任何转座酶-DNA结构中最大,最复杂的结构,并且只有第二个DDE重组酶可以用靶DNA结晶。该结构是进一步研究的跳板。 AIM 1是完成当前的结构并获得最高的分辨率晶体形式。当前的结构指导了具有不同的DNA结合结构域的活性但更紧凑的嵌合式转座酶,该酶可能有助于结晶,将促进我们实验室和其他人的体外实验,并可能有助于设计系统更有用,使其更有用。 目标2是了解构象变化是稳定性和CLPX识别的基础。我们的结构提出了一个模型,用于转座酶如何使用产品结合能来推动原本同工同的化学反应,以及如何优先识别出ATP依赖性的Infordase CLPX,如何优先识别出极为稳定的最终复合物。此目的使用散装和单分子货物和LRET,以及一些晶体学和溶液测定法。 AIM 3是了解以全左右噬菌体末端组装组装的结构基础。尽管一个活跃的复合物仅需要4个转座酶的拷贝(这是我们已经结晶的),但噬菌体的右端和左端都包含3个转座酶结合位点的不同阵列。我们的结构为左端为何与右端不同以及如何将其纳入最终复合物的方式提供了可检验的假设的基础。这项工作将涉及具有针对不同结合位点的精心选择的突变体的复杂形成和活动测定。对该系统的详细理解将为理解为什么许多其他移动DNA元素具有不同的左右两端,并具有看似脱颖而出的重组酶结合位点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHOEBE A RICE其他文献
PHOEBE A RICE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHOEBE A RICE', 18)}}的其他基金
Lifestyle of the SCCmec element and mechanisms of self-loading helicases
SCCmec 元件的生活方式和自加载解旋酶的机制
- 批准号:
9923690 - 财政年份:2017
- 资助金额:
$ 29.6万 - 项目类别:
Lifestyle of the SCCmec element and mechanisms of self-loading helicases
SCCmec 元件的生活方式和自加载解旋酶的机制
- 批准号:
9219554 - 财政年份:2017
- 资助金额:
$ 29.6万 - 项目类别:
Unexpected parallels between SaPI replication initiators and conserved SCC ORFs
SaPI 复制启动子和保守的 SCC ORF 之间的意外相似之处
- 批准号:
9001253 - 财政年份:2015
- 资助金额:
$ 29.6万 - 项目类别:
Unexpected parallels between SaPI replication initiators and conserved SCC ORFs
SaPI 复制启动子和保守的 SCC ORF 之间的意外相似之处
- 批准号:
8873188 - 财政年份:2015
- 资助金额:
$ 29.6万 - 项目类别:
Systems for studying the mobility of the SCCmec element in MRSA
用于研究 MRSA 中 SCCmec 元件迁移性的系统
- 批准号:
8074920 - 财政年份:2010
- 资助金额:
$ 29.6万 - 项目类别:
相似国自然基金
基于高通量测序和培养组学的伴侣动物-人抗生素抗性基因分布特征及传播研究
- 批准号:82373646
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
手性酰胺类农药污染的农业土壤中抗生素抗性基因传播扩散的对映选择性机制
- 批准号:42377238
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
猪粪水热炭对红壤-蔬菜系统中抗生素抗性基因的风险控制及其机理
- 批准号:42307038
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
蚯蚓-菌根协同消减抗生素抗性基因的微生物驱动机制
- 批准号:32301448
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物炭对厌氧膜生物反应器抑制畜禽养殖废水中抗生素抗性基因的调控作用和机制
- 批准号:52300210
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Connecting the universe of proteins to address annotation inequality in the microbial proteome
连接蛋白质领域以解决微生物蛋白质组中的注释不平等问题
- 批准号:
10658439 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities
复杂群落中假单胞菌群体感应调控关系及其对群体感应抑制剂影响的全面研究
- 批准号:
10716869 - 财政年份:2023
- 资助金额:
$ 29.6万 - 项目类别:
A spatially resolved single-cell transcriptomic technique for microbial pathogenesis
用于微生物发病机制的空间分辨单细胞转录组技术
- 批准号:
10352579 - 财政年份:2022
- 资助金额:
$ 29.6万 - 项目类别:
Supplement: Development of a technology to certify engineered DNA molecules
补充:开发验证工程 DNA 分子的技术
- 批准号:
10732196 - 财政年份:2022
- 资助金额:
$ 29.6万 - 项目类别:
A spatially resolved single-cell transcriptomic technique for microbial pathogenesis
用于微生物发病机制的空间分辨单细胞转录组技术
- 批准号:
10612336 - 财政年份:2022
- 资助金额:
$ 29.6万 - 项目类别: